Details of the Drug

General Information of Drug (ID: DMLIEN8)

Drug Name

BNT115

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

mRNA (uRNA)

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04163094) Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy. U.S.National Institutes of Health.